Sage Rhino Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $983K | Buy |
8,120
+99
| +1% | +$12K | 0.21% | 89 |
|
2025
Q1 | $894K | Buy |
8,021
+174
| +2% | +$19.4K | 0.21% | 93 |
|
2024
Q4 | $764K | Sell |
7,847
-319
| -4% | -$31K | 0.17% | 103 |
|
2024
Q3 | $939K | Buy |
8,166
+319
| +4% | +$36.7K | 0.21% | 93 |
|
2024
Q2 | $835K | Buy |
7,847
+41
| +0.5% | +$4.37K | 0.2% | 99 |
|
2024
Q1 | $755K | Buy |
7,806
+162
| +2% | +$15.7K | 0.18% | 104 |
|
2023
Q4 | $772K | Buy |
7,644
+70
| +0.9% | +$7.07K | 0.2% | 97 |
|
2023
Q3 | $771K | Buy |
7,574
+384
| +5% | +$39.1K | 0.22% | 92 |
|
2023
Q2 | $726K | Buy |
7,190
+267
| +4% | +$26.9K | 0.2% | 98 |
|
2023
Q1 | $637K | Buy |
6,923
+120
| +2% | +$11K | 0.19% | 101 |
|
2022
Q4 | $617K | Buy |
6,803
+399
| +6% | +$36.2K | 0.2% | 98 |
|
2022
Q3 | $487K | Sell |
6,404
-1,125
| -15% | -$85.6K | 0.2% | 90 |
|
2022
Q2 | $636K | Buy |
7,529
+765
| +11% | +$64.6K | 0.24% | 78 |
|
2022
Q1 | $594K | Buy |
6,764
+750
| +12% | +$65.9K | 0.18% | 107 |
|
2021
Q4 | $526K | Buy |
6,014
+172
| +3% | +$15K | 0.15% | 120 |
|
2021
Q3 | $478K | Buy |
5,842
+48
| +0.8% | +$3.93K | 0.15% | 111 |
|
2021
Q2 | $529K | Buy |
5,794
+564
| +11% | +$51.5K | 0.16% | 105 |
|
2021
Q1 | $447K | Buy |
5,230
+171
| +3% | +$14.6K | 0.15% | 101 |
|
2020
Q4 | $478K | Buy |
5,059
+4
| +0.1% | +$378 | 0.19% | 92 |
|
2020
Q3 | $440K | Sell |
5,055
-109
| -2% | -$9.49K | 0.21% | 90 |
|
2020
Q2 | $451K | Buy |
5,164
+415
| +9% | +$36.2K | 0.24% | 83 |
|
2020
Q1 | $392K | Buy |
4,749
+26
| +0.6% | +$2.15K | 0.28% | 76 |
|
2019
Q4 | $443K | Buy |
4,723
+42
| +0.9% | +$3.94K | 0.25% | 84 |
|
2019
Q3 | $407K | Sell |
4,681
-78
| -2% | -$6.78K | 0.26% | 83 |
|
2019
Q2 | $435K | Sell |
4,759
-348
| -7% | -$31.8K | 0.28% | 74 |
|
2019
Q1 | $440K | Buy |
+5,107
| New | +$440K | 0.29% | 74 |
|